CN103913581A - Cyclophorase determination method for triglyceride in serum - Google Patents

Cyclophorase determination method for triglyceride in serum Download PDF

Info

Publication number
CN103913581A
CN103913581A CN201310601423.4A CN201310601423A CN103913581A CN 103913581 A CN103913581 A CN 103913581A CN 201310601423 A CN201310601423 A CN 201310601423A CN 103913581 A CN103913581 A CN 103913581A
Authority
CN
China
Prior art keywords
reagent
serum
triglyceride
cyclophorase
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310601423.4A
Other languages
Chinese (zh)
Inventor
李立和
郑宝永
王彦平
李铮
刘果艳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Baodi Hospital
Original Assignee
Tianjin Baodi Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Baodi Hospital filed Critical Tianjin Baodi Hospital
Priority to CN201310601423.4A priority Critical patent/CN103913581A/en
Publication of CN103913581A publication Critical patent/CN103913581A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00Assays, e.g. immunoassays or enzyme assays, involving lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses a cyclophorase determination method for triglyceride in serum, and belongs to a method for measuring materials by measuring color change generated by reactions. A technical solution lies in that a reagent I contains effective components of glycerol kinase, 3-phosphoglycerol dehydrogenase, phosphoglycerol oxidase, peroxidase, adenosine triphosphate, NADH, 4-aminoantipyrine and 2,4-dichlorophen; and a reagent II only contains an effective component of lipoprotein lipase. Free glycerol in the serum is subjected to circular reactions with adenosine triphosphate, NADH, 4-aminoantipyrine and 2,4-dichlorophen in the reagent I under catalysis of glycerol kinase, 3-phosphoglycerol dehydrogenase, phosphoglycerol oxidase and peroxidase to generate quinoneimine; and after the reagent II is added, triglyceride is hydrolyzed to generate glycerol, and then the circular reaction is carried out. The content of triglyceride is calculated by an instrument based on quinoneimine generated by reactions in the reagent II, by using quinoneimine generated by reactions in the reagent I as a blank.

Description

The cyclophorase assay method of Triglycerides in Serum
Technical field
The invention belongs to a kind of assay method that comprises enzyme; Or utilize visible ray, and carry out the method for test material by the result generation change color of test reaction, particularly relate to a kind of cyclophorase assay method that detects Triglycerides in Serum with Biochemical Analyzer.
Background technology
The assay method of triglyceride in serum (TG) generally can be divided into chemical method, enzyme process and the large class of chromatography 3.The present invention introduces the triglyceride in a kind of enzymatic cycling assay for detecting serum, triglyceride (TG) generates glycerine and fatty acid under lipoprotein lipase (LPL) catalysis, glycerine and ATP generate glycerol-3-phosphate (G-3P) under glycerokinase (GK) catalysis, be brought in circular response, be oxidized to dihydroxyacetone phosphate (DHAP) by GPO (GPO), DHAP is reduced to again G-3P by glycerine-3 phosphate dehydrogenase (G-3PDH), simultaneously with NADH to NAD +conversion, in iterative cycles, the amount of G-3P and DHAP is constant, and product H 2o 2the amount of accumulation is decided by reaction time and cpm, and therefore, its sensitivity substantially exceeds general enzymatic analysis, detects product H 2o 2can coupling peroxidase (POD), can react colorimetric estimation by Trinder.
Its theoretical derivation is as follows:
Assaying reaction is as Fig. 2.
If SV=1.5 μ is l, R 1=200 μ l, R 2=50 μ l, t 1=3min, t 2=5min, triglyceride range of linearity 11.00mmol/L, in serum, the high value of dissociative glycerin pathology is 0.60mmol/L.
According to the derivation of equation:
v = V 1 + K n TG [ TG ] + K m H 2 O [ H 2 O ]
v = V 1 + K m TG [ TG ]
v = V [ TG ] K m TG + [ TG ]
Known if the TG range of linearity is 11.0mmol/L, SV=1.5 μ l, R 1=200 μ l, R 2=50 μ l, t 1=3min, t 2=5min.
t = 4.606 K m TG / V max + [ TG ] / V max
V max=381.6U/L
The concentration of LPL in reagent I is: 643.9U/L × 251.5/50=1919.45U/L
v = V 1 + K m ATP [ ATP ] + K m FG [ FG ]
Known: K m ATP = 1.3 × 10 - 5 , K m FG = 9.4 × 10 - 5
In first step reaction:
[FG]=11.6mmol/L×1.5/1.5+200+50=65.606×10 -6mol/L
[ATP]=2×200/1.5+200+50=1.59×10 -3mol/L
be about 122 times
Formula can be changed into:
v = V 1 + K m FG [ FG ]
v = V [ FG ] K m FG + [ FG ]
According to formula: t = 4.606 K m TG / V max + [ TG ] / V max
V max=100.4U/L
The consumption of glycerokinase is: 100.4U/L × 251.5/200=126.29U/L
GPO consumption:
[G-3-P]=[FG]=65.606×10 -6mol/L
According to formula: t = 4.606 K m G - 3 - P / V max + [ G - 3 - P ] / V max
V max=1211U/L
The concentration of GPO in reagent I should be: 1211U/L × 251.5/200=1523U/L
The consumption of glycerol-3-phosphate:
[NADH] configuration concentration in reagent I is 1.0mmol/L, is 1.59 × 10 in the concentration of reactant liquor -3mol, much larger than formula can calculate by single substrate reactions, according to formula
t = 4.606 K m DHAP / V max + [ DHAP ] / V max
The consumption of glycerol-3-phosphate is: 428U/L
In reagent I, concentration is: 428U/L × 251.5/200=538.2U/L, in circulation enzyme process, for making DHAP be converted into rapidly glycerine-3 phosphoric acid, toolenzyme consumption should be 3 × 538.2U/L=1615U/L
The consumption of peroxidase is:
In reagent I 2, the configuration concentration of 4-Dichlorophenol is 2.0mmol/L, and the concentration of 4-AA is 2.0mmol/L, due in reaction system much larger than Michaelis constant, therefore above formula can be changed into:
v = V 1 + K m [ H 2 O 2 ] [ H 2 O 2 ] + K m ATP [ ATP ] + K m 4 - CP [ 4 - CP ]
v = V 1 + K m [ H 2 O 2 ] [ H 2 O 2 ] .
v = V [ H 2 O 2 ] K m [ H 2 O 2 ] + [ H 2 O 2 ]
Known wherein [H 2o 2]=69.18 × 10 -6mol/L
be greater than [H 2o 2] measure for end-point method, the reaction time is 2min
t = 4.606 K m [ H 2 O 2 ] / V max + [ H 2 O 2 ] / V max
The consumption of toolenzyme peroxidase is:
V max=120.56μmol/min.L=103.19U/L
In reagent I, concentration is: 103.19U/L × 251.5/200=389U/L, in circulation enzyme process for making H 2o 2be converted into rapidly quinones, should make toolenzyme consumption reach 3 times, so toolenzyme consumption should be 3 × 389U/L=1167U/L.
Calculate toolenzyme and substrate consumption according to reaction equation and enzyme kinetics equation, enzyme activator and antiseptic, the formula of this kit is: every liter of Tris-HCl damping fluid of reagent I includes Tris100mmol~300mmol, 2,4-Dichlorophenol 1.0mmol~3.0mmol, MgSO 49.0mmol~15.0mmol, sodium taurocholate 3.0mmol~5.0mmol, atriphos 1.5mmol~2.5mmol, glycerokinase 100U~160U, GPO 1200U~2000U, peroxidase 1000U~1400U, 4-AA 1.5mmol~2.5mmol, glycerol-3-phosphate dehydrogenase 1200U~2000U, NADH0.8mmol~1.2mmol, Proclin-300 antiseptic 100 μ l~300 μ l; Every liter of Tris-HCl damping fluid of reagent II includes Tris100mmol~300mmol, lipoprotein lipase 1800U~2100U, TritonX-1000.08g~0.16g, Proclin-300 antiseptic 100 μ l~300 μ l.
What in Biochemical Analyzer detection serum, TG adopted is enzyme process, generally adopts the method (GPO-PAP method) of the reagent such as LPL, GPO, POD, 4-AA and phenol.The present invention adopts glycerine circulation enzyme process to measure, first dissociative glycerin carries out glycerine circulation enzyme process and measures in serum, produce red quinone imines, add after the second reagent, lipoprotein lipase hydrolyzing triglyceride produces glycerine, cyclophorase and substrate reactions in glycerine and reaction system, in reasonable time, measure, the quinone imines producing taking the first step is as blank, the quinone imines producing taking second step reaction is as assaying reaction, calculate the concentration of triglyceride, technical characterstic of the present invention is to be more suitable for trace detection, affected by piarhemia, jaundice, haemolysis little.
Summary of the invention:
In order to solve in prior art the problem that in serum, the assay method of TG exists endogenous glycerine to disturb, the invention provides a kind of economical convenient and easy, the serum triglyceride assay method that accuracy is higher, can eliminate the impact of endogenous glycerine.
The technical scheme that solves this technical problem employing is: two chromogen substances and cyclophorase coexist in reagent I, and reagent II only contains lipoprotein lipase effective constituent; Its assay method is: serum is first bathed 3~5 minutes in 37 DEG C of temperature with reagent I, and in serum, dissociative glycerin reacts with reagent I and generates quinone imines, adds reagent II to bathe 4~7 minutes in 37 DEG C of temperature, after triglyceride hydrolysis, generates red quinone imines through series reaction.Instrument detects at 500nm wavelength place, and the quinone imines reacting taking reagent I is as blank, and the quinone imines being produced by reagent II reaction calculates the content of triglyceride.
Every liter of Tris-HCl damping fluid of mentioned reagent I includes Tris200mmol, 2,4-Dichlorophenol 2.0mmol, MgSO 412.0mmol, sodium taurocholate 4.0mmol, atriphos 2.0mmol, glycerokinase 130U, GPO 1600U, peroxidase 1200U, 4-AA 2.0mmol, glycerol-3-phosphate dehydrogenase 1600U, NADH1.0mmol, Proclin300 antiseptic 200 μ l; Every liter of Tris-HCl damping fluid of reagent II includes Tris200mmol, lipoprotein lipase 1950U, Triton X-1000.12g, Proclin300 antiseptic 200 μ l.
In mentioned reagent I and reagent II, the pH value of Tris-HCl damping fluid is 7.6 ± 0.2.
In said determination, the volume ratio of reactant is: sample: reagent I: reagent II=3: 300~500: 30~70.
In reagent I of the present invention, contain glycerokinase, glycerol-3-phosphate, GPO, peroxidase, atriphos, NADH, 4-AA, 2, the effective constituents such as 4-Dichlorophenol; Reagent II only has lipoprotein lipase effective constituent.Dissociative glycerin glycerokinase in reagent I in serum, glycerol-3-phosphate, GPO, under Catalyzed Synthesis By Peroxidase with atriphos, NADH, oxygen, 4-AA, 2, the circular responses such as 4-Dichlorophenol generate red quinone imines, add after reagent II, after triglyceride hydrolysis, generate glycerine, carry out again circular response and generate red quinone imines, instrument detects at 500~520nm wavelength place, the quinone imines producing taking reagent I reaction is as blank, and the quinone imines being produced by reagent II reaction calculates the content of triglyceride.Not affected by endogenous glycerine, its using method is identical with original enzyme process with scope, is a kind of triglyceride detection method of trace detection preferably.
The present invention compared with prior art has the following advantages: not affected by endogenous glycerine, the range of linearity can reach 11.0mmol/L.Its using method is identical with original enzyme process with scope, can not increase experimenter's burden, does not increase reagent cost, economical convenient and easy, affected by piarhemia, jaundice, haemolysis etc. little, is the TG detection method that a kind of accuracy is higher.
Brief description of the drawings
Accompanying drawing is the response curve figure that the present invention measures healthy human body TG.
Fig. 2 is that triglyceride decomposes and glycerine circular response figure.
Embodiment:
Below by embodiment and accompanying drawing, the present invention is described in further details.
Embodiment 1
The composition of reagent:
A. reagent I:
Every liter of Tris-HCl damping fluid of reagent I includes Tris200mmol, 2,4-Dichlorophenol 2.0mmol, MgSO 412.0mmol, sodium taurocholate 4.0mmol, atriphos 2.0mmol, glycerokinase 130U, GPO 1600U, peroxidase 1200U, 4-AA 2.0mmol, glycerol-3-phosphate dehydrogenase 1600U, NADH1.0mmol, Proclin300 antiseptic 200 μ l.
B. reagent II:
Every liter of Tris-HCl damping fluid of reagent II includes Tris200mmol, lipoprotein lipase 1950U, Triton X-1000.12g, Proclin300 antiseptic 200 μ l.
In mentioned reagent I and reagent II, the pH value of Tris-HCl damping fluid is 7.6 ± 0.2.
C. titer: 2.0mmol/L trioleate aqueous solution.
Wherein, MgSO 4for the activator of glycerokinase, Triton X-100 is surfactant, and Proclin-300 is efficient liquid antiseptic, and sodium taurocholate is bacteriostatic agent.
Embodiment 2.
Mensuration program
On the full-automatic Biochemical Analyzer of Japanese OLYMPUS AU2700, instrument automatically joins 1.5 μ l samples in 200 μ l reagent I and mixes, hatch 3 minutes for 37 DEG C, add 50 μ l reagent II to mix, hatch 5 minutes for 37 DEG C, fully-automatic analyzer detects at 500nm wavelength place, and instrument calculates TG result automatically, specifically in table 1.
Table 1 robotization Biochemical Analyzer of the present invention test condition
Reaction OD tGcalculated value=OD 2-OD 1× [(SV+R 1v 1)/(SV+R 1v 1+ R 2v 2)]
Triglyceride concentration=F × OD tG
Wherein OD tGit is the absorbance that triglyceride produces.OD 1that sample adds the absorbance recording after reagent I reaction, OD 2be that sample adds the absorbance recording after reagent II reaction, SV is the volume of serum, R 1v 1the volume of reagent I, R 2v 2it is the volume of reagent II.F is correction factor.
Add OD after reagent II 1extension rate be [(SV+R 1v 1)/(SV+R 1v 1+ R 2v 2)], add the absorbance after reagent II to be OD 1× [(SV+R 1v 1)/(SV+R 1v 1+ R 2v 2)].So the absorbance of the quinone imines being produced by triglyceride is: OD tG=OD 2-OD 1× [(SV+R 1v 1)/(SV+R 1v 1+ R 2v 2)], i.e. OD tG=OD 2-(1.5+200)/(1.5+200+50) × OD 1.As long as measure OD 1and OD 2can calculate the concentration of triglyceride.
Below by adopting three kinds of diverse ways to detect the glycerine recovery in serum, further illustrate good effect of the present invention.The glycerine recovery is the percent of the glycerine numerical value of measuring after reaction and the ratio of the glycerine numerical value adding, the geometric ratio product that glycerine is triglyceride in this reaction, glycerine is measured the recovery does not affect triglyceride determination as best taking the glycerine adding, be that the glycerine recovery is lower, illustrate that glycerine is lower on triglyceride determination impact, glycerine does not count in triglyceride determination value.
1. detected object: health examination personnel 86 people, the wherein male sex 52 people, 42.5 years old mean age; Women 34 people, 39.5 years old mean age, on an empty stomach blood sampling.
2. employing method and reagent
2.1 reagent:
(1) method A: every liter of Tris-HCl damping fluid of reagent I includes Tris200mmol, 2,4-Dichlorophenol 2.0mmol, MgSO 412.0mmol, sodium taurocholate 4.0mmol, atriphos 2.0mmol, glycerokinase 130U, GPO 1600U, peroxidase 1200U, 4-AA 2.0mmol, glycerol-3-phosphate dehydrogenase 1600U, NADH1.0mmol, Proclin300 antiseptic 200 μ l; Every liter of Tris-HCl damping fluid of reagent II includes Tris200mmol, lipoprotein lipase 1950U, Triton X-1000.12g, Proclin300 antiseptic 200 μ l.
(2) method B: reagent I and reagent II were configured to single agents by 4: 1 and measure, measures wavelength 500nm, reaction time 8.1min.
(3) method C: high performance liquid chromatography adopts Shimadzu LC-10A high performance liquid chromatograph, mobile phase is the normal hexane containing 1% isopropyl alcohol and 0.5% acetonitrile, flow velocity 1.2mL/min detects wavelength 230nm.
(4) glycerine (analyze pure, sigma company, molecular weight 92.09, density is 1.2613mg/dl, 25 DEG C).
2.2. instrument: Japanese Olympus AU2700 type automatic clinical chemistry analyzer; Shimadzu LC-10A is high
Effect liquid phase chromatogram instrument.
2.3. method
2.3.1 measure 86 parts of healthy population triglyceride levels by reagent A, B, tri-kinds of methods of C respectively,
And carry out result comparison.
2.3.2 above-mentioned serum is hybridly prepared into pooled serum, adds respectively 0,0.85,1.70,3.40mmol/L glycerine, measure respectively the relatively recovery tests of two kinds of methods by reagent A, two kinds of methods of B.
2.3.3 assay method
Method A: sample: reagent I: reagent II=1.5: 200: 50,37 DEG C, sample and reagent I temperature were bathed 3 minutes, add reagent II, react 5 minutes, and 500nm wavelength place end-point method is measured.
Reagent B: sample: reagent=1: 100,37 DEG C, in 8.1 minutes reaction time, 500nm wavelength place end-point method is measured.
Method C mobile phase is the normal hexane containing 1% isopropyl alcohol and 0.5% acetonitrile, and flow velocity 1.2ml/min detects wavelength 230nm.Normal hexane layer direct injected in sample thief preparation, sampling volume 5 μ l while measuring total glycerine (TTG), 10 μ l while measuring dissociative glycerin.The concentration of standard solution is carried out to linear regression to glycerine/interior mark peak area ratio, obtain regression equation, calculate for sample glycerol concentration, the difference of total glycerine and dissociative glycerin is the value of real triglyceride.
3. three kinds of methods are measured TG comparison:
Pass through statistical analysis: employing method A and C measurement result there was no significant difference, t=0.97, P=0.4215, correlativity is good, r=0.9701, Y method A=1.2031+0.9620X method C; Method A can eliminate dissociative glycerin and disturb, and method B can not eliminate dissociative glycerin impact, in table 2; Employing method A and B measurement result have significant difference, t=9.65, P=0.0031.
Table 2. recovery experiment tables of data
In the inventive method, in the first step preincubate phase, dissociative glycerin is converted into quinone imines, adding after reagent II, starting TG hydrolysis reaction, TG is converted into quinone imines, response curve is shown in Fig. 1, the red quinone imines that instrument produces first step reaction is blank, and the quinone imines producing with second step reaction calculates the content of TG, is real TG content.
In method B single agents, dissociative glycerin and TG simultaneous reactions generate quinone imines, and result of calculation is dissociative glycerin and TG sum.High performance liquid chromatography can determine respectively the value of total glycerine and dissociative glycerin, not affected by dissociative glycerin.
Relatively can find out through above, reagent II of the present invention only has lipoprotein lipase, and other is reagent I, the accuracy that can ensure that by changing the component of reagent I, II Triglycerides in Serum detects.

Claims (5)

1. a cyclophorase assay method for Triglycerides in Serum, is characterized in that cyclophorase and substrate coexist in reagent I, and reagent II only contains lipoprotein lipase effective constituent; Its assay method is: serum is first bathed 3~5 minutes in 37 DEG C of temperature with reagent I, in serum, dissociative glycerin and reagent I carry out circular response generation quinone imines, after adding reagent II, bathe 4~7 minutes in 37 DEG C of temperature, after triglyceride hydrolysis, produce glycerine and generate quinone imines through circular response again; Reaction reaches after certain hour, and instrument detects at 500~520nm wavelength place, and the quinone imines producing taking reagent I reaction is as blank, and the quinone imines being produced by reagent II reaction calculates the content of triglyceride, and computing formula is:
OD TG=OD 2-OD 1×[(SV+R 1V 1)/(SV+R 1V 1+R 2V 2)]
Triglyceride concentration=F × OD tG
Wherein OD tGthe absorbance that triglyceride produces, OD 1that sample adds the absorbance recording after reagent I reaction, OD 2be that sample adds the absorbance recording after reagent II reaction, SV is the volume of serum, R 1v 1the volume of reagent I, R 2v 2be the volume of reagent II, F is correction factor.
2. the cyclophorase assay method of Triglycerides in Serum according to claim 1, is characterized in that the first step and second step reaction all adopt enzymatic cycling assay for detecting glycerine, generate red quinone imines and measure.
3. the cyclophorase assay method of Triglycerides in Serum according to claim 1, is characterized in that every liter of Tris-HCl damping fluid of reagent I includes Tris100mmol~300mmol, 2,4-Dichlorophenol 1.0mmol~3.0mmol, MgSO 49.0mmol~15.0mmol, sodium taurocholate 3.0mmol~5.0mmol, atriphos 1.5mmol~2.5mmol, glycerokinase 100U~160U, GPO 1200U~2000U, peroxidase 1000U~1400U, 4-AA 1.5mmol~2.5mmol, glycerol-3-phosphate dehydrogenase 1200U~2000U, NADH0.8mmol~1.2mmol, Proclin-300 antiseptic 100 μ l~300 μ l; Every liter of Tris-HCl damping fluid of reagent II includes Tris100mmol~300mmol, lipoprotein lipase 1800U~2100U, Triton X-1000.08g~0.16g, Proclin-300 antiseptic 100 μ l~300 μ l.
4. the cyclophorase assay method of Triglycerides in Serum according to claim 3, the pH value that it is characterized in that Tris-HCl damping fluid in reagent I and reagent II is 7.6 ± 0.2.
5. the cyclophorase assay method of Triglycerides in Serum according to claim 3, is characterized in that the volume ratio of measuring is: sample: reagent I: reagent II=3: 300~500: 30~70.
CN201310601423.4A 2013-11-20 2013-11-20 Cyclophorase determination method for triglyceride in serum Pending CN103913581A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310601423.4A CN103913581A (en) 2013-11-20 2013-11-20 Cyclophorase determination method for triglyceride in serum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310601423.4A CN103913581A (en) 2013-11-20 2013-11-20 Cyclophorase determination method for triglyceride in serum

Publications (1)

Publication Number Publication Date
CN103913581A true CN103913581A (en) 2014-07-09

Family

ID=51039420

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310601423.4A Pending CN103913581A (en) 2013-11-20 2013-11-20 Cyclophorase determination method for triglyceride in serum

Country Status (1)

Country Link
CN (1) CN103913581A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107884401A (en) * 2017-11-13 2018-04-06 天津市宝坻区人民医院 Eliminate the glucose oxidase assay method of piarhemia interference
CN108467882A (en) * 2018-03-30 2018-08-31 潍坊市康华生物技术有限公司 A kind of triglyceride detection kit
CN109580962A (en) * 2019-01-30 2019-04-05 河北艾欧路生物科技有限责任公司 A kind of modified form triglyceride determination kit
CN111808921A (en) * 2020-06-15 2020-10-23 武汉生之源生物科技股份有限公司 Trinder reaction-based detection kit and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122454A (en) * 1987-03-20 1992-06-16 Toyo Yozo Company, Ltd. Assay method for lecithin-cholesterol acyltransferase
CN1354799A (en) * 1998-10-22 2002-06-19 阿泰金技术公司 Enzymatic methods for measuring lysophospholipids and phospholipids and correlation with disease
US20040137546A1 (en) * 2002-12-24 2004-07-15 Stepan Company Method for determination of free and combined glycerin in biodiesel
CN1560610A (en) * 2004-03-08 2005-01-05 王学忠 Homotypic cysteine measuring method and its reagent
CN101762577B (en) * 2010-01-28 2011-07-20 李立和 Two-step enzyme testing method of triglycercide in blood serum

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122454A (en) * 1987-03-20 1992-06-16 Toyo Yozo Company, Ltd. Assay method for lecithin-cholesterol acyltransferase
CN1354799A (en) * 1998-10-22 2002-06-19 阿泰金技术公司 Enzymatic methods for measuring lysophospholipids and phospholipids and correlation with disease
US20040137546A1 (en) * 2002-12-24 2004-07-15 Stepan Company Method for determination of free and combined glycerin in biodiesel
CN1560610A (en) * 2004-03-08 2005-01-05 王学忠 Homotypic cysteine measuring method and its reagent
CN101762577B (en) * 2010-01-28 2011-07-20 李立和 Two-step enzyme testing method of triglycercide in blood serum

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
邓铁生: "《临床生物化学检验》", 31 May 2012, article "酶循环测定法" *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107884401A (en) * 2017-11-13 2018-04-06 天津市宝坻区人民医院 Eliminate the glucose oxidase assay method of piarhemia interference
CN107884401B (en) * 2017-11-13 2020-03-24 天津市宝坻区人民医院 Glucose oxidase determination method for eliminating lipemia interference
CN108467882A (en) * 2018-03-30 2018-08-31 潍坊市康华生物技术有限公司 A kind of triglyceride detection kit
CN109580962A (en) * 2019-01-30 2019-04-05 河北艾欧路生物科技有限责任公司 A kind of modified form triglyceride determination kit
CN111808921A (en) * 2020-06-15 2020-10-23 武汉生之源生物科技股份有限公司 Trinder reaction-based detection kit and application thereof

Similar Documents

Publication Publication Date Title
CN102435749A (en) Liquid stable kit for measuring beta-hydroxybutyric acid by cyclic enzyme method
CN105203472B (en) A kind of stable free fatty acid determination reagent kit
CN102175670B (en) Method for detecting 1,5-dehydration glucitol in blood and kit
CN104198408A (en) Detection kit for determining content of creatinine in serum by enzymic method
CN103913581A (en) Cyclophorase determination method for triglyceride in serum
CN104237147B (en) Determination of lactose method in body fluid
CN101762577B (en) Two-step enzyme testing method of triglycercide in blood serum
CN102747133B (en) Adenosine deaminase (ADA) detection reagent kit and preparation method thereof
CN103602718A (en) Method for testing triglyceride in serum by using glycerol dehydrogenase
CN108196075A (en) A kind of detection reagent and detection method of apotryptophanase method detection blood potassium ion
CN101750357A (en) Reagent (kit) for diagnosing/determining amino acid and method for determining concentration of amino acid
CN101620138A (en) Inorganic phosphorus (phosphate radical) diagnosis/determination kit and method for determining inorganic phosphorus (phosphate radical) concentration
CN101173895A (en) Paraoxonase diagnostic reagent kit and method for measuring active concentration of paraoxonase
CN101750337A (en) Reagent (kit) for diagnosing/determining amino acid and method for determining concentration of amino acid
CN101620142A (en) Inorganic phosphorus (phosphate radical) diagnosis/determination kit and method for determining inorganic phosphorus (phosphate radical) concentration
CN101750326A (en) Reagent (kit) for diagnosing/determining amino acid and method for determining concentration of amino acid
CN101750364A (en) Reagent (kit) for diagnosing/determining amino acid and method for determining concentration of amino acid
CN101750365A (en) Reagent (kit) for diagnosing/determining amino acid and method for determining concentration of amino acid
CN101750368A (en) Reagent (kit) for diagnosing/determining amino acid and method for determining concentration of amino acid
CN101776579A (en) Reagent (kit) for diagnosing/determining amino acid and method for determining concentration of amino acid
CN101750323A (en) Reagent (kit) for diagnosing/determining amino acid and method for determining concentration of amino acid
CN101750331A (en) Reagent (kit) for diagnosing/determining amino acid and method for determining concentration of amino acid
CN101750324A (en) Reagent (kit) for diagnosing/determining amino acid and method for determining concentration of amino acid
CN101762487A (en) Reagent (kit) for diagnosing/determining amino acid and method for determining concentration of amino acid
CN101750338A (en) Reagent (kit) for diagnosing/determining amino acid and method for determining concentration of amino acid

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140709